100 related articles for article (PubMed ID: 22503234)
21. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Collins LC; Tamimi RM; Baer HJ; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2005 May; 103(9):1778-84. PubMed ID: 15770688
[TBL] [Abstract][Full Text] [Related]
22. Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor.
Ulusoy C; Kepenekci I; Kose K; Aydintug S; Cam R
Breast Cancer Res Treat; 2010 Apr; 120(2):419-24. PubMed ID: 19760030
[TBL] [Abstract][Full Text] [Related]
23. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
[TBL] [Abstract][Full Text] [Related]
24. Associations in breast and colon cancer screening behavior in women.
Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
[TBL] [Abstract][Full Text] [Related]
25. [Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].
van Asperen CJ; de Bock GH; van der Horst F; de Koning HJ; Rutgers EJ
Ned Tijdschr Geneeskd; 2001 Jan; 145(3):120-5. PubMed ID: 11206121
[TBL] [Abstract][Full Text] [Related]
26. [Good results in periodic screening in women with increased risk of breast cancer; retrospective study].
Tilanus-Linthorst MM; Bartels CC; Obdeijn AI; Kuenen-Boumeester V; Klijn JG; Oudkerk M
Ned Tijdschr Geneeskd; 1995 Mar; 139(9):445-9. PubMed ID: 7891766
[TBL] [Abstract][Full Text] [Related]
27. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.
Hoskins KF; Zwaagstra A; Ranz M
Cancer; 2006 Oct; 107(8):1769-76. PubMed ID: 16967460
[TBL] [Abstract][Full Text] [Related]
28. Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer.
Haroun I; Graham T; Poll A; Sun P; Hill K; Weitzner E; Narod S; Warner E
Breast; 2011 Jun; 20(3):254-8. PubMed ID: 21306899
[TBL] [Abstract][Full Text] [Related]
29. [Is the Gail model for breast cancer risk assessment valid for the Bulgarian women?].
Baitchev G; Christova P; Ivanov I
Khirurgiia (Sofiia); 2009; (6):27-30. PubMed ID: 20506776
[TBL] [Abstract][Full Text] [Related]
30. Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort.
Buron A; Vernet M; Roman M; Checa MA; Pérez JM; Sala M; Comas M; Murta-Nascimiento C; Castells X; Macià F
Breast; 2013 Feb; 22(1):83-8. PubMed ID: 23141024
[TBL] [Abstract][Full Text] [Related]
31. Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand.
Orlando LA; Wu RR; Beadles C; Himmel T; Buchanan AH; Powell KP; Hauser ER; Henrich VC; Ginsburg GS
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):24-33. PubMed ID: 24616329
[TBL] [Abstract][Full Text] [Related]
32. [Breast cancer diagnosis among women aged 75 and over: study on information delivered by organized breast cancer screening agencies to women reaching the limit age].
Ecomard LM; Malingret N; Asad-Syed M; Dilhuydy MH; Madranges N; Payet C; Debled M
Bull Cancer; 2013; 100(7-8):671-6; quiz 677-8. PubMed ID: 23823935
[TBL] [Abstract][Full Text] [Related]
33. Young women with breast cancer: how many are actually candidates for fertility preservation?
Moffat R; de Geyter C; Myrick ME; Schmid SM; Sattmann C; Tschudin S; Kilic N; Güth U
Arch Gynecol Obstet; 2012 Dec; 286(6):1521-7. PubMed ID: 22821507
[TBL] [Abstract][Full Text] [Related]
34. The effectiveness of the Gail model in estimating risk for development of breast cancer in women under 40 years of age.
MacKarem G; Roche CA; Hughes KS
Breast J; 2001; 7(1):34-9. PubMed ID: 11348413
[TBL] [Abstract][Full Text] [Related]
35. The requirements of a specialist Breast Centre.
Wilson AR; Marotti L; Bianchi S; Biganzoli L; Claassen S; Decker T; Frigerio A; Goldhirsch A; Gustafsson EG; Mansel RE; Orecchia R; Ponti A; Poortmans P; Regitnig P; Rosselli Del Turco M; Rutgers EJ; van Asperen C; Wells CA; Wengström Y; Cataliotti L;
Eur J Cancer; 2013 Nov; 49(17):3579-87. PubMed ID: 23968730
[TBL] [Abstract][Full Text] [Related]
36. Implementing a Population-Based Breast Cancer Risk Assessment Program.
Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
[TBL] [Abstract][Full Text] [Related]
37. A risk management model for familial breast cancer: A new application using Fuzzy Cognitive Map method.
Papageorgiou EI; Jayashree Subramanian ; Karmegam A; Papandrianos N
Comput Methods Programs Biomed; 2015 Nov; 122(2):123-35. PubMed ID: 26220142
[TBL] [Abstract][Full Text] [Related]
38. Assessing Breast Cancer Risks to Improve Care for an Increased-Risk Population within Eastern North Carolina.
Shelton CH; Bowen C; Guenther WC; Jordan B; Boehmer LM; Weldon CB; Trosman JR; Ruiz A
N C Med J; 2022; 83(3):221-228. PubMed ID: 35504701
[No Abstract] [Full Text] [Related]
39. Breast Cancer Risk Assessment Using the Gail Model and It’s Predictors in Saudi Women.
Al Otaibi HH
Asian Pac J Cancer Prev; 2017 Nov; 18(11):2971-2975. PubMed ID: 29172267
[TBL] [Abstract][Full Text] [Related]
40. Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer.
Schwab FD; Bürki N; Huang DJ; Heinzelmann-Schwarz V; Schmid SM; Vetter M; Schötzau A; Güth U
Fam Cancer; 2014 Mar; 13(1):99-107. PubMed ID: 24002368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
